ACADIA Pharmaceuticals Inc (ACAD.O)

ACAD.O on Nasdaq

38.06USD
12:32pm EST
Change (% chg)

$0.09 (+0.24%)
Prev Close
$37.97
Open
$38.25
Day's High
$38.50
Day's Low
$38.00
Volume
807,586
Avg. Vol
1,323,628
52-wk High
$38.50
52-wk Low
$15.64

ACAD.O

Chart for ACAD.O

About

ACADIA Pharmaceuticals Inc. (ACAD) is a biopharmaceutical company focused on the development and commercialization of medicines to address unmet medical needs in neurological and related central nervous system disorders. It has a pipeline of product candidates led by NUPLAZID (pimavanserin), which is in Phase III development as... (more)

Overall

Beta: 2.95
Market Cap(Mil.): $3,731.41
Shares Outstanding(Mil.): 99.77
Dividend: --
Yield (%): --

Financials

  ACAD.O Industry Sector
P/E (TTM): -- 175.70 40.21
EPS (TTM): -0.80 -- --
ROI: -29.18 -2.61 16.34
ROE: -29.79 -4.38 17.27
Search Stocks

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ Quantitative Report
$127.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks